These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers. Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746 [TBL] [Abstract][Full Text] [Related]
6. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584 [TBL] [Abstract][Full Text] [Related]
7. The effect of activated charcoal on the bioavailability of piroxicam in man. Laufen H; Leitold M Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of concentration of piroxicam in blood and local site after two routes of administration]. Fang XL; Jiang XG; Zhang ZR; Xi NZ Yao Xue Xue Bao; 1995; 30(3):226-9. PubMed ID: 7639082 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic profiles of two tablet formulations of piroxicam. Rasetti-Escargueil C; Grangé V Int J Pharm; 2005 May; 295(1-2):129-34. PubMed ID: 15847998 [TBL] [Abstract][Full Text] [Related]
12. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095 [TBL] [Abstract][Full Text] [Related]
13. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. Jovanović D; Kilibarda V; Cirić B; Vucinić S; Srnić D; Vehabović M; Potogija N Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study. Dos Reis Serra CH; Mori Koono EE; Kano EK; Schramm SG; Armando YP; Porta V Clin Ther; 2008 May; 30(5):902-8. PubMed ID: 18555936 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related]